Evidence map›Paper›PMID 22130093›Full record

ArticleCancer biology & therapy2011

New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.

Robert K Nam, William Zhang, Katherine Siminovitch, Adam Shlien, Michael W Kattan, Laurence H Klotz, John Trachtenberg, Yan Lu, Jinyi Zhang, Changhong Yu and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 4 countries.

Robert K NamDivision of Urology, Sunnybrook Research Institute, University of Toronto, ON, Canada. robert.nam@utoronto.ca
William Zhang
Katherine Siminovitch
Adam Shlien
Michael W Kattan
Laurence H Klotz
John Trachtenberg
Yan Lu
Jinyi Zhang
Changhong Yu
Ants Toi
D Andrew Loblaw
Vasundara Venkateswaran
Aleksandra Stanimirovic
Linda Sugar
David Malkin
Arun Seth
Steven A Narod
Sunnybrook Health Science Centre · CAUniversity of Toronto · CACleveland Clinic · USSunnybrook Research InstituteUniversity Health Network · CAHealth Net · USSunnybrook Hospital · CA

Funding

Canadian Institutes of Health Research MOP-79530NCI NIH HHS CA010294NCI NIH HHS CA017092
6 · The paper itself

Abstract

purposeTo identify and examine polymorphisms of genes associated with aggressive and clinical significant forms of prostate cancer among a screening cohort. EXPERIMENTAL

designWe conducted a genome-wide association study among patients with aggressive forms of prostate cancer and biopsy-proven normal controls ascertained from a prostate cancer screening program. We then examined significant associations of specific polymorphisms among a prostate cancer screened cohort to examine their predictive ability in detecting prostate cancer.

resultsWe found significant associations between aggressive prostate cancer and five single nucleotide polymorphisms (SNPs) in the 10q26 (rs10788165, rs10749408, and rs10788165, p value for association 1.3 × 10(-10 ) to 3.2 × 10(-11) ) and 15q21 (rs4775302 and rs1994198, p values for association 3.1 × 10(-8 ) to 8.2 × 10(-9)) regions. Results of a replication study done in 3439 patients undergoing a prostate biopsy, revealed certain combinations of these SNPs to be significantly associated not only with prostate cancer but with aggressive forms of prostate cancer using an established classification criterion for prostate cancer progression (odds ratios for intermediate to high-risk disease 1.8-3.0, p value 0.003-0.001). These SNP combinations were also important clinical predictors for prostate cancer detection based on nomogram analysis that assesses prostate cancer risk.

conclusionsFive SNPs were found to be associated with aggressive forms of prostate cancer. We demonstrated potential clinical applications of these associations.

Indexed as

Chromosomes, Human, Pair 10Chromosomes, Human, Pair 15Genome-Wide Association StudyPolymorphism, Single NucleotideAdultAgedAged, 80 and overAllelesBiopsyGene FrequencyGenotypeHumansMaleMiddle AgedNeoplasm StagingPrognosis

Identifiers

PMID22130093
PMCPMC3280918
OpenAlexW2063081197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.